Meet the Experts on
“Preventing the Next CVD Event in Diabetics”
excerpts from a roundtable discussion hosted by
the UVA Diabetes Center , the Center for Global Health & the Office of International Health
September 29, 2005, Charlottesville, VA, U.S.A.
Find answers to the clinically most relevant questions and learn about cutting-edge research data in a "golden hour" of interaction with a multi-specialty team of experts.
Select a topic below to view it in Windows Media Player If you do not have Windows Media Player, you can download it here .
Robert S. Gibson, MD "What is the optimal LDL level for diabetics?" (10 min.)
Christopher M. Rembold, MD "TZDs and lipids: Is there a class effect? " (5 min.)
Eugene J. Barrett, MD, PhD "Diabetes mellitus: What is the unifying basis of this vascular disease?" (9 min.)
Murat Tuzcu, MD "Coronary atherosclerosis progression in diabetics: What does IVUS show?" (8 min.)
Anthony L. McCall, MD, PhD "Does glycemia matter to CVD? " (7 min.)
Alan H. Matsumoto, MD "The diabetic foot ulcer: Can we obviate extremity amputation? " (8 min.)
Mark D. Okusa, MD "Which antihypertensive drugs to use in the patient with CKD? " (8.5 min.)
Robert M. Carey, MD "What combination of therapeutic approaches provides the best level of tissue protection in diabetics? " (7 min.)
Supported by Takeda Pharmaceuticals North America, Inc.